Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease Therapy-Reference-Cited by-同舟云学术

Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease Therapy

Published:2018-08-13 Issue:7 Volume:201 Page:2094-2106
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Spangler Jamie B.^ORCID,Trotta Eleonora,Tomala Jakub,Peck Ariana,Young Tracy A.,Savvides Christina S.^ORCID,Silveria Stephanie,Votavova Petra,Salafsky Joshua,Pande Vijay S.^ORCID,Kovar Marek,Bluestone Jeffrey A.^ORCID,Garcia K. Christopher^ORCID

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference66 articles.

1. The Biology of Interleukin-2

2. The role of interleukin-2 during homeostasis and activation of the immune system

3. Structure of the Quaternary Complex of Interleukin-2 with Its α, ß, and γ c Receptors

4. Insights into Cytokine–Receptor Interactions from Cytokine Engineering

5. Mechanistic Diversity of Cytokine Receptor Signaling Across Cell Membranes

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Directed disruption of IL2 aggregation sites produces designer biologics with enhanced specificity coupled to improved production capacity;2024-09-03

2. IL-2/JES6-1 Antibody Complex Expands the Maternal T-Regulatory Cell Pool and Alleviates Fetal Loss in Abortion-Prone Mice;The American Journal of Pathology;2024-08

3. Site-specific pegylated IL2 mutein with biased IL2 receptor binding for cancer immunotherapy;International Immunopharmacology;2024-07

4. An Updated Review of Interleukin-2 Therapy in Cancer and Autoimmune Diseases;Journal of Interferon & Cytokine Research;2024-04-01

5. A CD25-biased interleukin-2 for autoimmune therapy engineered via a semi-synthetic organism;Communications Medicine;2024-03-26